SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Thyrocare Technologies to consider report of valuation of wholly owned subsidiary

20 Sep 2019 Evaluate

Thyrocare Technologies is going to consider the report of valuation of the wholly owned subsidiary company, Nueclear Healthcare (NHL), obtained from a second valuer engaged for the purpose, in the context of deciding whether to retain the company's shareholding in NHL or dispose it. The meeting of the Board of Directors of the company will be held on September 21, 2019, to consider the same. 

Thyrocare Technologies provides hospital services and are the industry leader, trend setter and innovators in Indian Diagnostic industry.

Thyrocare Tech. Share Price

397.50 9.65 (2.49%)
22-Apr-2026 15:43 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×